Maxipime and Speech impairment (adult) - a phase IV clinical study of FDA data

Summary:

Speech impairment (adult) is reported as a side effect among people who take Maxipime (cefepime hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Pneumonia.

The phase IV clinical study analyzes which people have Speech impairment (adult) when taking Maxipime. It is created by eHealthMe based on reports of 4,272 people who have side effects when taking Maxipime from the FDA, and is updated regularly.

What is Maxipime?

Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.

What is Speech impairment (adult)?

Speech impairment (adult) (inability to speak (adult)) is found to be associated with 2,137 drugs and 3,593 conditions by eHealthMe. Check the latest studies of Speech impairment (adult).

On Jul, 16, 2026

4,272 people reported to have side effects when taking Maxipime.
Among them, 36 people (0.84%) have Speech impairment (adult).

Could Maxipime cause Speech impairment (adult)?

Among these 36 people:

How long have people been on Maxipime when they have Speech impairment (adult)? *

What is the gender of people who have Speech impairment (adult) when taking Maxipime? *

female: 69.44 %
male: 30.56 %

What is the age of people who have Speech impairment (adult) when taking Maxipime? *

What are other drugs people take besides Maxipime? *

What are other side effects people have besides Speech impairment (adult)? *

Confusional State: 9 people, 25.00%
Fever: 8 people, 22.22%
Pneumonia: 8 people, 22.22%
Acute Kidney Failure: 7 people, 19.44%
Nausea And Vomiting: 7 people, 19.44%
Thrombocytopenia (decrease of platelets in blood): 6 people, 16.67%
Dyspnea (difficult or laboured breathing): 6 people, 16.67%
Metabolic Encephalopathy (disorder or disease of the brain due to the body's disability to use energy): 6 people, 16.67%
White Blood Cell Count Decreased: 6 people, 16.67%
Hallucinations (sensations that appear real but are created by your mind): 5 people, 13.89%

What are the existing conditions these people have? *

Pneumonia: 6 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 5 people, 13.89%
Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 11.11%
Stable Angina (a constant chest pain): 4 people, 11.11%
Pruritus Generalised (generalized itching): 4 people, 11.11%
Escherichia Infection (bacterial infection by escherichia coli): 4 people, 11.11%
Bone Marrow Conditioning Regimen: 3 people, 8.33%
Non-Hodgkin's Lymphoma Refractory (refractory malignant (cancer) cells form in the lymph system): 3 people, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.56%
Essential Thrombocythaemia (chronic blood cancer): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Maxipime and have Speech impairment (adult)?

- Check whether Speech impairment (adult) is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maxipime:

Maxipime (4,279 reports)

Browse all side effects of Maxipime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Speech impairment (adult):

Speech impairment (adult) (2,137 drugs)

Browse all the conditions that are associated with Speech impairment (adult):

Speech impairment (adult) (3,593 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefepime hydrochloride (the active ingredients of Maxipime) and Maxipime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.